Back to the directory
Andson Biotech
Empowering Mass Spec for Biotech and Beyond
- Founded
- 2021
- Status
- Active
- Stage
- Early
- Team size
- 4
- Location
- Atlanta, GA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Healthcare
About Andson Biotech
Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.
BiotechGene TherapyHard TechHealthcareTherapeutics
Federal research funding
1 NIH award totalling $302,671, FY2025.
- A Real-Time Mass Spectrometry Platform for In-Process Monitoring and Cell State Analysis
Source: NIH RePORTER.
Securities filings
2 Form D filings on record, 2024 to 2025.
Filed as Andson Biotech Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
